VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
HIPOHippo Holdings Inc.
$27.46$715M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksHIPOQuarterly Financials

Hippo Holdings Inc. (HIPO) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Hippo Holdings Inc. (HIPO) quarterly income statement — complete revenue, gross profit & net income history

HIPO Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Revenue121.5M120.4M120.6M117.3M110.3M101.9M95.5M89.6M85.1M64.5M57.7M47.7M
Revenue Growth %10.15%18.16%26.28%30.92%29.61%57.98%65.51%87.84%113.82%80.17%87.95%66.2%
Medical Costs & Claims82.4M45.5M80.4M77.3M122.6M126.7M65.2M97.5M84.9M48.2M47.9M86.8M
Medical Cost Ratio %67.82%37.79%66.67%65.9%111.15%124.34%68.27%108.82%99.76%74.73%83.02%181.97%
Gross Profit39.1M74.9M40.2M40M-12.3M-24.8M30.3M-7.9M200K16.3M9.8M-39.1M
Gross Margin %32.18%62.21%33.33%34.1%-11.15%-24.34%31.73%-8.82%0.24%25.27%16.98%-81.97%
Gross Profit Growth %417.89%402.02%32.67%606.33%-6250%-252.15%209.18%79.8%103.33%307.5%990.91%-268.87%
Operating Expenses31.9M68.1M-57.9M36M33.3M-71.9M35.5M28.6M33.1M55.3M60.4M65.9M
OpEx / Revenue %26.26%56.56%-48.01%30.69%30.19%-70.56%37.17%31.92%38.9%85.74%104.68%138.16%
Depreciation & Amortization000005.8M4.3M4.1M5.6M5.4M4.9M5.2M
Combined Ratio %94.07%94.35%18.66%96.59%141.34%53.78%105.45%140.74%138.66%160.47%187.69%320.13%
Operating Income7.2M6.8M98.1M4M-45.6M47.1M-5.2M-36.5M-32.9M-39M-50.6M-105M
Operating Margin %5.93%5.65%81.34%3.41%-41.34%46.22%-5.45%-40.74%-38.66%-60.47%-87.69%-220.13%
Operating Income Growth %115.79%-85.56%1986.54%110.96%-38.6%220.77%89.72%65.24%51.47%35%60.22%-46.44%
EBITDA7.2M6.8M98.1M4M-45.6M52.9M-900K-32.4M-27.3M-33.6M-45.7M-99.8M
EBITDA Margin %5.93%5.65%81.34%3.41%-41.34%51.91%-0.94%-36.16%-32.08%-52.09%-79.2%-209.22%
Interest Expense000000000000
Non-Operating Income000000000000
Pretax Income7.2M6.8M98.1M4M-45.6M47.1M-5.2M-36.5M-32.9M-39M-50.6M-105M
Pretax Margin %5.93%5.65%81.34%3.41%-41.34%46.22%-5.45%-40.74%-38.66%-60.47%-87.69%-220.13%
Income Tax100K800K0100K-200K200K0700K200K300K-300K200K
Effective Tax Rate %1.39%11.76%0%2.5%0.44%0.42%0%-1.92%-0.61%-0.77%0.59%-0.19%
Net Income7.1M6M98.1M1.3M-47.7M44.2M-8.5M-40.5M-35.7M-42.3M-53.1M-107.8M
Net Margin %5.84%4.98%81.34%1.11%-43.25%43.38%-8.9%-45.2%-41.95%-65.58%-92.03%-226%
Net Income Growth %114.88%-86.43%1254.12%103.21%-33.61%204.49%83.99%62.43%48.85%32.96%58.9%-46.67%
EPS (Diluted)0.270.233.770.05-1.911.79-0.34-1.64-1.47-1.75-2.24-4.61
EPS Growth %114.14%-87.15%1208.82%103.05%-29.93%202.29%84.82%64.43%50%33.46%59.86%-41.85%
EPS (Basic)0.270.243.900.05-1.911.78-0.34-1.64-1.47-1.75-2.24-4.61
Diluted Shares Outstanding26.35M26.25M26.03M26.02M24.98M24.87M25.07M24.63M24.23M24.15M23.73M23.39M